EMAIL THIS PAGE TO A FRIEND

Cell cycle (Georgetown, Tex.)

Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database.


PMID 26102293

Abstract

The transcription factor C/EBPα is required for granulocytic differentiation of normal myeloid progenitors and is frequently inactivated in acute myeloid leukemia (AML) cells. Ectopic expression of C/EBPα in AML cells suppresses proliferation and induces differentiation suggesting that restoring C/EBPα expression/activity in AML cells could be therapeutically useful. Unfortunately, current approaches of gene or protein delivery in leukemic cells are unsatisfactory. However, "drug repurposing" is becoming a very attractive strategy to identify potential new uses for existing drugs. In this study, we assessed the biological effects of candidate C/EBPα-mimetics identified by interrogation of the Connectivity Map database. We found that amantadine, an antiviral and anti-Parkinson agent, induced a monocyte-macrophage-like differentiation of HL60, U937, Kasumi-1 myeloid leukemia cell lines, as indicated by morphology and differentiation antigen expression, when used in combination with suboptimal concentration of all trans retinoic acid (ATRA) or Vit D3. The effect of amantadine depends, in part, on increased activity of the vitamin D receptor (VDR), since it induced VDR expression and amantadine-dependent monocyte-macrophage differentiation of HL60 cells was blocked by expression of dominant-negative VDR. These results reveal a new function for amantadine and support the concept that screening of the Connectivity Map database can identify small molecules that mimic the effect of transcription factors required for myelo-monocytic differentiation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

138576
1-Adamantylamine, 97%
C10H17N
GW22538F Anti-GRB2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB2500491
Anti-GRB2 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB4501290
Anti-GRB2 antibody produced in rabbit, affinity isolated antibody
SAB2500842
Anti-PU.1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
AV37890
Anti-SFPI1 antibody produced in rabbit, IgG fraction of antiserum
AV31421
Anti-SPI1 antibody produced in rabbit, affinity isolated antibody
SAB2102283
Anti-SPI1 antibody produced in rabbit, affinity isolated antibody
HPA044653
Anti-SPI1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4502840
Anti-SPI1 antibody produced in rabbit, affinity isolated antibody
SAB2102673
Anti-VDR (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2102674
Anti-VDR (ab2) antibody produced in rabbit, affinity isolated antibody
SAB2501098
Anti-VDR antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1406580
Anti-VDR antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2104917
Anti-VDR, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4503071
Anti-Vitamin D Receptor antibody produced in rabbit, affinity isolated antibody
G4753
Griseofulvin, from Penicillium griseofulvum, 97.0-102.0%
C17H17ClO6
WH0002885M1
Monoclonal Anti-GRB2 antibody produced in mouse, clone 4C6-H6, ascites fluid, buffered aqueous solution
WH0006688M1
Monoclonal Anti-SPI1 antibody produced in mouse, clone 1A3, purified immunoglobulin, buffered aqueous solution
SAB1404402
Monoclonal Anti-SPI1, (N-terminal) antibody produced in mouse, clone 2G1, purified immunoglobulin, buffered aqueous solution
WH0007421M2
Monoclonal Anti-VDR antibody produced in mouse, clone 2F4, purified immunoglobulin, buffered aqueous solution